Over the past twenty years, next-generation sequencing (NGS) has moved from an ‘all-research technology’ into a ‘daily routine practice’ in hospitals. next-generation sequencing has become vital in several types of clinical diagnostics.
During the development of the technology, NGS procedures have greatly improved in terms of cost and efficiency. Because of this, NGS also became accessible for personalized medicine. Not only diagnosis and treatment are determined using NGS, but ‘healthy’ people will also start using NGS-based tests for early detection or even prevention of disorders.
Micronit has a long track record as a manufacturer of flow cells for next-generation sequencing. Today our customers, varying from ambitious start-ups to some of the world’s largest analytical and diagnostic instrument manufacturers, rely on us for customized flow cells to address their specific sequencing needs.
NGS is predominantly used in diagnostics, personalized medicine, and drug discovery. The analytic accuracy and high throughput possibilities of NGS are proving to be valuable in the detection and research of hereditary disorders. NIPT (non-invasive prenatal testing) is an important field of application for NGS. Next to this, the use of NGS-based liquid biopsies in cancer research has greatly expanded the market in this specific direction. This method provides accurate details of the genetic layout of a tumor, information that is essential in determining the right treatment method.
The share of end-users of NGS products is shifting from the research field to pharmaceutical and biotech companies and hospitals. The use of NGS in day-to-day medical practice is growing.
Are you working on an NGS device and would you like to have a chat with someone familiar with this field? Hit the button and contact one of our Business Development Managers.